Drug Profile
Adenocarcinoma vaccine - St. Vincent's Manhattan
Latest Information Update: 24 Jul 2001
Price :
$50
*
At a glance
- Originator St. Vincents Manhattan
- Class Antibodies; Cancer vaccines; Immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 24 Jul 2001 No-Development-Reported for Colorectal cancer in USA (Unknown route)
- 24 Nov 1994 Preclinical development for Colorectal cancer in USA (Unknown route)